Syria 'Safe Zone': 3 Options for Turkey

 Turkey's President Recep Tayyip Erdogan at the UN Headquarters in New York on September 24, 2019. (AP)
Turkey's President Recep Tayyip Erdogan at the UN Headquarters in New York on September 24, 2019. (AP)
TT

Syria 'Safe Zone': 3 Options for Turkey

 Turkey's President Recep Tayyip Erdogan at the UN Headquarters in New York on September 24, 2019. (AP)
Turkey's President Recep Tayyip Erdogan at the UN Headquarters in New York on September 24, 2019. (AP)

Turkish President Recep Tayyip Erdogan has renewed his demand to establish a safe zone, devoid of the Kurdish People's Protection Units (YPG) and Kurdistan Workers' Party (PKK), 30 kilometers deep into northern Syria.

Erdogan first made his intentions clear in 2013 and then presented a detailed map of his vision before the United Nations in 2019. His plan was rejected by the United States, Europe and Russia. Ankara managed, however, through various exchanges and military incursions to establish pockets of control in the area.

This was achieved through four military operations: Euphrates Shield in Jarablus in northern Aleppo in 2016, Olive Branch in Afrin in Aleppo's countryside in 2018, Peace Spring in Tal Abyad and Ras al-Ain east of the Euphrates River in late 2019 and Spring Shield in Idlib in spring 2020.

The process also demanded a series of agreements: Ankara, Moscow and Tehran signed an agreement over Idlib in Astana in 2017; Ankara signed a number of understandings with Moscow in 2018 and 2020; Ankara signed an agreement with Washington over the Manbij "roadmap" in 2018 and another one on the Peace Spring region in October 2019.

These deals allowed Turkey to establish its zones of influence that take up around 10 percent of Syria, or roughly twice the size of Lebanon. Turkey, along with Russia and Iran, which control 63 percent of Syria with the regime, is one of the main players in the war-torn country. Added to them are the United States and its allies, who back the Kurdish Syrian Democratic Forces (SDF), which hold 23 percent of northeastern Syria.

Turkey's incursions in Syria have prevented the Kurds from establishing their own state, similar to the Iraqi Kurdistan Region. It partially succeeded in driving out the YPG and PKK from its southern borders and prevented dramatic demographic changes in northern Syria. Ankara, Tehran and Damascus are in agreement over barring the establishment of a Kurdish entity. Syria, Iran and Turkey had in the 1990s also stood against the establishment of the Iraqi Kurdistan Region.

What has changed?
Erdogan believes that the war on Ukraine has granted Turkey a unique and major negotiations position with Russia, the US and Washington.

Washington supports Sweden and Finland's bid to join NATO and in order for that to succeed, it needs the approval of all members, including Turkey.

Moscow opposes the bid and is banking on Turkey's veto to that end.

Through the series of tradeoffs and understandings in Syria, and Ankara and Moscow's bilateral military, economic and political relations, Russian President Vladimir Putin succeeded in using his special ties with Erdogan in making a main breakthrough in NATO's southern front. Turkey's Incirlik base near the Syrian border lies just dozens of kilometers away from Russia's Hmeimim air base in western Syria.

Days ago, as NATO was preparing to hold a summit in Spain next month, Erdogan raised his tone and threatened to wage a new incursion in northern Syria with the aim of establishing a "safe zone" and driving out the YPG.

Turkish intelligence and allied Syrian factions have been preparing for the new battle. Shelling along the frontlines has also intensified in recent days, namely in the Peace Spring region covering Tal Abyad, Ras al-Ain and the area east of the Euphrates, the areas near Manbij in the Aleppo countryside, and in Tal Rifaat.

Each of these three zones has its own risks should Turkey choose to attack:

- Red zone. The US has deployed its forces, patrols and drones in the area east of the Euphrates to stress that it is there to protect its allies - the SDF - and repel the Turkish army. The US informed Ankara, through its UN ambassador, of its rejection of any military attacks.

Russia, meanwhile, has used the Turkish threats of an offensive to justify reinforcing its strategic deployment near American forces east of the Euphrates.

This has forced Turkey to backtrack somewhat with Erdogan clearly stating that the new offensive would not include the area east of the Euphrates, but it will cover the region west of the river, specifically Manbij and Tal Rifaat.

- Yellow - grey zone, covering west of the Euphrates in Manbij, where an old American-Turkish agreement called for the withdrawal of the YPG and PKK. Washington and Ankara also agreed to deploy joint patrols in the area and form a local council.

The US assurances to the YPG included Manbij and Washington believes that any threat to the Kurdish force will undermine the war against ISIS.

Any Turkish attack in this zone will lead to instability and raise demands in the US Congress for Washington to impose sanctions on Ankara that were imposed after the 2019 offensive.

Erdogan certainly wants to avoid more economic pressure, a year before presidential elections. He may, however, increase pressure in Manbij to reach a new settlement against the YPG.

- Green zone that covers Tal Rifaat, also west of the Euphrates. This area is, in theory, held by Russia, Iran and the Damascus regime. A Turkish incursion here may be easier than the other two zones. All Ankara needs is a green light from Moscow, just as it did for the Euphrates Shield, Olive Branch and Spring Shield operations.

At the time, Russia extracted a price from Turkey in Syria. This time around, Turkey's request for control of Tal Rifaat from Russia will be met with Moscow's demands over Ukraine and Sweden and Finland's NATO bids or perhaps that Ankara normalize ties with Damascus and agree to the deployment of Syrian border guards on the Syrian-Turkish border.

The coming days will reveal Turkey's true intentions: Is it seeking better negotiations conditions ahead of the NATO summit or is Erdogan seeking to impose a new reality on the ground before flying to Spain? Moreover, how will this clash play out with the UN Security Council seeking to extend the cross-border aid deliveries through Turkey before the July 10 deadline?



New Mpox Strain Is Changing Fast; African Scientists Are ‘Working Blind’ to Respond 

Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)
Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)
TT

New Mpox Strain Is Changing Fast; African Scientists Are ‘Working Blind’ to Respond 

Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)
Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)

Scientists studying the new mpox strain that has spread out of Democratic Republic of Congo say the virus is changing faster than expected, and often in areas where experts lack the funding and equipment to properly track it.

That means there are numerous unknowns about the virus itself, its severity and how it is transmitting, complicating the response, half a dozen scientists in Africa, Europe and the United States told Reuters.

Mpox, formerly known as monkeypox, has been a public health problem in parts of Africa since 1970, but received little global attention until it surged internationally in 2022, prompting the World Health Organization to declare a global health emergency. That declaration ended 10 months later.

A new strain of the virus, known as clade Ib, has the world's attention again after the WHO declared a new health emergency.

The strain is a mutated version of clade I, a form of mpox spread by contact with infected animals that has been endemic in Congo for decades. Mpox typically causes flu-like symptoms and pus-filled lesions and can kill.

Congo has had more than 18,000 suspected clade I and clade Ib mpox cases and 615 deaths this year, according to the WHO. There have also been 222 confirmed clade Ib cases in four African countries in the last month, plus a case each in Sweden and Thailand in people with a travel history in Africa.

"I worry that in Africa, we are working blindly," said Dr. Dimie Ogoina, an infectious diseases expert at Niger Delta University Hospital in Nigeria who chairs the WHO's mpox emergency committee. He first raised the alarm about potential sexual transmission of mpox in 2017, now an accepted route of spread for the virus.

"We don’t understand our outbreak very well, and if we don't understand our outbreak very well, we will have difficulty addressing the problem in terms of transmission dynamics, the severity of the disease, risk factors of the disease," Ogoina said. "And I worry about the fact that the virus seems to be mutating and producing new strains."

He said it took clade IIb in Nigeria five years or more to evolve enough for sustained spread among humans, sparking the 2022 global outbreak. Clade Ib has done the same thing in less than a year.

MUTATING 'MORE RAPIDLY'

Mpox is an orthopoxvirus, from the family that causes smallpox. Population-wide protection from a global smallpox vaccine campaign 50 years ago has waned, as the vaccinating stopped when the disease was eradicated.

Genetic sequencing of clade Ib infections, which the WHO estimates emerged mid-September 2023, show they carry a mutation known as APOBEC3, a signature of adaptation in humans.

The virus that causes mpox has typically been fairly stable and slow to mutate, but APOBEC-driven mutations can accelerate viral evolution, said Dr. Miguel Paredes, who is studying the evolution of mpox and other viruses at Fred Hutchison Cancer Center in Seattle.

"All the human-to-human cases of mpox have this APOBEC signature of mutations, which means that it's mutating a little bit more rapidly than we would expect," he said.

Paredes and other scientists said a response was complicated by several mpox outbreaks happening at once.

In the past, mpox was predominantly acquired through human contact with infected animals. That is still driving a rise in Congo in clade I cases – also known as clade Ia - likely due in part to deforestation and increased consumption of bushmeat, scientists said.

The mutated versions, clade Ib and IIb, can now essentially be considered a sexually transmitted disease, said Dr. Salim Abdool Karim, a South African epidemiologist and chair of the Africa CDC’s mpox advisory committee. Most of the mutated clade Ib cases are among adults, driven at first by an epidemic among female sex workers in South Kivu, Congo.

The virus also can spread through close contact with an infected person, which is likely how clusters of children have been infected with clade Ib, particularly in Burundi and in eastern Congo’s displacement camps, where crowded living conditions may be contributing.

Children, pregnant women and people with weakened immune systems or other illnesses may be at greater risk of serious mpox disease and death, say the WHO and mpox scientists.

Clade I has typically caused more severe disease, with fatality rates of 4%-11%, compared to around 1% for clade II. Ogoina said data from Congo suggests few have died of the new Ib version, but he feared some data is being mixed up.

More research is urgently needed, but three teams tracking mpox outbreaks in Africa say they cannot even access chemicals needed for diagnostic tests. Clade Ib can also be missed by some diagnostic tests.

Planning a response, including vaccination strategies, without this is difficult, the scientists said.

Karim said around half of cases in eastern Congo, where Ib is particularly prevalent, are only being diagnosed by doctors, with no laboratory confirmation.

Getting samples to labs is difficult because the healthcare system is already under pressure, he said. And around 750,000 people have been displaced amid fighting between the M23 rebel group and the government.

Many African laboratories cannot get the supplies they need, said Dr. Emmanuel Nakoune, an mpox expert at the Institut Pasteur in Bangui, Central African Republic, which also has clade Ia cases.

"This is not a luxury," he said, but necessary to track deadly outbreaks.